image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

Al Noor Hospitals - Makes its first two acquisitions

December 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ANH
  • Price:
  • 840.5p
The announcement of two long awaited acquisitions, plus a positive trading update, was enough to lift the shares to a new high of 918p. Al Noor has announced the acquisition of the Al Madar Clinic in Al Ain City and the Manchester Clinic in Jumeirah, Dubai for a combined US$16m. In addition it plans to open two new medical centres by the end of this year in Abu Dhabi, adding to three others already commissioned this year in Abu Dhabi, Al Ain and Muscat in Oman. The group also announced that Q3 revenues grew 11%, maintaining the same level set in the first half. The number of revenue generating physicians has grown by 78 to 418 year-on-year and it expects this to rise towards 100 by the year-end. Al Noor, which is deb ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Al Noor Hospitals - VPS Healthcare and NMC could yet gatecrash agreed Mediclinic offer (December 2015)
Al Noor Hospitals - In merger talks (November 2015)
Al Noor Hospitals - Shares hit by director sale (June 2015)
Al Noor Hospitals - Shares hit new high (October 2014)
Al Noor Hospitals (June 2014)
Al Noor Hospitals (April 2014)
Al Noor Hospitals - Third acquisition post float (February 2014)
Al Noor Hospitals - Hospitals group forecast to grow eps 88% over next three years (October 2013)
AL Noor Hospitals - Exciting new issue in fast growing Middle East private health care market (August 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X